- Home
- PKG vs HOLX Comparison
PKG vs HOLX Comparison
Compare PKG & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKG
- HOLX
- Stock Information
- Founded
- PKG 1867
- HOLX 1985
- Country
- PKG United States
- HOLX United States
- Employees
- PKG N/A
- HOLX N/A
- Industry
- PKG Containers/Packaging
- HOLX Medical Electronics
- Sector
- PKG Consumer Discretionary
- HOLX Health Care
- Exchange
- PKG Nasdaq
- HOLX Nasdaq
- Market Cap
- PKG 18.5B
- HOLX 15.0B
- IPO Year
- PKG 2000
- HOLX 1990
- Fundamental
- Price
- PKG $196.16
- HOLX $73.93
- Analyst Decision
- PKG Buy
- HOLX Hold
- Analyst Count
- PKG 7
- HOLX 15
- Target Price
- PKG $233.00
- HOLX $79.00
- AVG Volume (30 Days)
- PKG 781.4K
- HOLX 4.2M
- Earning Date
- PKG 10-22-2025
- HOLX 11-03-2025
- Dividend Yield
- PKG 2.55%
- HOLX N/A
- EPS Growth
- PKG 15.38
- HOLX N/A
- EPS
- PKG 9.90
- HOLX 2.41
- Revenue
- PKG $8,771,800,000.00
- HOLX $4,038,900,000.00
- Revenue This Year
- PKG $9.11
- HOLX $3.37
- Revenue Next Year
- PKG $12.38
- HOLX $4.54
- P/E Ratio
- PKG $19.81
- HOLX $30.62
- Revenue Growth
- PKG 7.30
- HOLX 1.29
- 52 Week Low
- PKG $172.72
- HOLX $51.90
- 52 Week High
- PKG $250.82
- HOLX $84.39
- Technical
- Relative Strength Index (RSI)
- PKG 34.11
- HOLX 70.41
- Support Level
- PKG $198.27
- HOLX $73.85
- Resistance Level
- PKG $215.77
- HOLX $74.16
- Average True Range (ATR)
- PKG 6.01
- HOLX 0.92
- MACD
- PKG -1.23
- HOLX 0.39
- Stochastic Oscillator
- PKG 6.35
- HOLX 91.97
About PKG Packaging Corporation of America
Packaging Corp. of America is the third-largest containerboard and corrugated packaging manufacturer in the United States. It produces over 5 million tons of containerboard annually. The company's share of the domestic containerboard market is roughly 10%. PCA differentiates itself from larger competitors by focusing on smaller customers and operating with a high degree of flexibility.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.